On April 8, 2023, the second day of the 2023 World Health Expo, hosted by Taikang Insurance Group, Wuhan Municipal Bureau of Commerce, and Wuhan Investment Promotion Office, Taikang Luojia Research Institute, Wuhan University Taikang Life Medicine Center, and Wuhan University Asset Management Investment Management Co., Ltd The Third Big Health Investment Partner Conference "Clinical Medicine+" Industry University Research Innovation Transformation Sub Forum and Wuhan Biological Industry Promotion Conference jointly organized by Wuhan Aibotech Biotechnology Co., Ltd. were successfully held. The conference has gathered resources from various sectors such as government, enterprises, academia, and research, effectively promoting the transformation of organized scientific research achievements and the deep integration of the life medicine innovation chain, industrial chain, funding chain, and talent chain, serving the national innovation driven development strategy and the Healthy China strategy.
"Clinical Medicine+" Industry University Research Innovation Transformation Sub Forum and Wuhan Biological Industry Promotion Conference
Ge Lin, member of the Standing Committee of the People's Congress of Hubei Province, deputy director of the Finance and Economics Committee, first level inspector of the Department of Science and Technology of Hubei Province, Zhang Quan, executive deputy director of Wuhan Investment Promotion Office, Li Xiling, president of Wuhan Institute of Industrial Innovation and Development, Li Ziyuan, member of the Standing Committee of the Party Committee and vice president of Wuhan University, Song Baoliang, academician of the CAS Member, vice president of the Standing Committee of the Party Committee of Wuhan University, president of Taikang Medical College (Basic Medical College), and director of Taikang Life Medicine Center, Director of the Institute of Urology at Wuhan University Central South Hospital and PI of Taikang Life Medicine Center, Wang Xinghuan; Secretary of the Party Committee, Chairman, and Director of the Science and Technology Transfer Center of Wuhan University Asset Management Investment Management Co., Ltd., Qi Zhenyuan; Chen Yilun, member of the Taikang Insurance Group Management Committee and Deputy General Manager of Taikang Assets; Jin Yi, member of the Taikang Insurance Group Management Committee and compliance officer; Zhao Qian, Director of Wuhan Aibotech Biotechnology Co., Ltd CEO Wu Zhicai and other leaders and guests from government departments, universities, hospitals, investment, finance, and industry attended.
This forum includes four segments: guest speeches, keynote speeches, bio industry promotion, and project roadshows. In her speech, Ge Lin stated that this conference has gathered guests from hospitals, universities, enterprises and other sectors, and has built a collaborative exchange platform for industry academia research integration and innovation. Through the intelligent collision and integration of representatives from the academic, medical, and industrial sectors, a number of "golden ideas" will definitely be generated to improve the level of technological innovation in the biological industry, create a new model of medical industry intersection, medical sports integration, and medical enterprise cooperation, Promoting the high-quality development of the biological industry has yielded fruitful results.
Ge Lin, member of the Standing Committee of the Hubei Provincial People's Congress, deputy director of the Finance and Economics Committee, and first level inspector of the Hubei Provincial Department of Science and Technology
Zhang Quan stated in his speech that Wuhan has established a large-scale investment fund for the health and biotechnology industry with a total scale of 30 billion yuan. Recently, the fund is closely searching for projects and conducting large-scale investments. At the same time, it is also conducting pilot projects for capital investment to promote industrial agglomeration through capital investment. In the future, we look forward to more industrial projects being transformed in Wuhan, more investments being made in Wuhan, and more talents standing out in Wuhan to realize their life value.
Zhang Quan, Executive Deputy Director of Wuhan Investment Promotion Office
Li Xiling stated in her speech that Wuhan Industrial Innovation and Development Research Institute, as a comprehensive and high-energy new research and development institution created by the Wuhan Municipal Government, adheres to enterprise management and market-oriented operation, and is committed to doing what the government cannot do, universities and institutions are unwilling to do, and enterprises cannot do, but innovative development must also do. In the future, Wuchuang Institute will continue to adhere to the concept of "change due to aggregation, innovation leads to innovation", complement the advantages of various innovative entities such as Taikang, share resources, and become a catalyst for innovation aggregation and integration.
Chen Yilun elaborated on the significance and value of this forum through his speech, introduced Taikang Insurance Group's big health industry ecosystem, and called on all sectors to jointly build a super platform that combines "medical education research, government industry investment". He stated that as a Fortune Global 500 company with a strong sense of patriotism and social responsibility, Taikang adheres to long-term principles, practices business goodness, and is committed to creating three major closed loops of longevity, health, and wealth. By combining high-quality health industry resources with self built medical and elderly care systems through external investment, Taikang aims to build an ecosystem. In the future, Taikang has the willingness and confidence to become a good "builder" of the platform under the guidance of the government and the support of all parties, playing the role of "propellant" and "adhesive", accelerating the transformation of science and technology into a productive force that promotes economic and social development and protects people's lives and health.
Chen Yilun, member of the Management Committee of Taikang Insurance Group and Deputy General Manager of Taikang Assets
In the keynote speech segment, university leaders, outstanding scientists, hospital deans, executives from well-known life medicine companies, and executives from Taikang Insurance Group gave speeches and shared their insights from the perspectives of university, scientists, hospitals, investment, and intellectual property protection.
Li Ziyuan proposed three suggestions on how to accelerate the transformation of innovative achievements in the theme report of "Adhering to Service Leading, Innovation Driven, and Supporting the Construction of First Class Universities with High Quality Achievement Transformation": Firstly, guided by the new concept of serving the "national system", promote the deep integration of knowledge and technology systems; Secondly, taking the creation of a new model of "government industry academia research collaboration" as a breakthrough, promoting the integrated development of scientific research and achievement transformation; Thirdly, taking the implementation of the new measures of "double innovation and education" as the starting point, we will build an innovative mechanism for talent cultivation and team building.
Li Ziyuan, member of the Standing Committee of the Party Committee and Vice President of Wuhan University
Academician Song Baoliang used his research findings published in Nature last year, titled "Inhibiting ASGR1 protein to promote cholesterol efflux and reduce lipid levels," as an example to provide a detailed introduction to the process of inhibiting ASGR1 protein to promote cholesterol efflux into bile, further excreting it from the body through feces, and thereby lowering blood and liver lipid levels. Taking this as an example, he emphasized that the ultimate translation of basic research into clinical application is a challenging process. He stated that Taikang Life Medicine Center adopts international advanced management and operation mechanisms and modern technology PI system (chief academic leader+team), forms a high-level scientific research team, and spares no effort in promoting the transformation of research results into clinical applications. With the joint support of Wuhan University and Taikang, Taikang Life Medicine Center has published more than 10 papers in international high-level academic journals such as Nature and Cell since its establishment over a year ago, Introduce more than ten outstanding young talents from home and abroad.
Song Baoliang, CAS Member, member of the Standing Committee of the Party Committee and Vice President of Wuhan University, president of Taikang Medical College (Basic Medical College), director of Taikang Life Medicine Center
In his keynote speech on "Bridging the Last Mile between Basic Research and Clinical Applications," Wang Xinghuan stated that only when basic research truly becomes a clinical tool that benefits patients can the transformation be truly meaningful. A mutual trust mechanism for medical research enterprise cooperation should be established, allowing investors, companies, and all sectors of society to achieve a new mechanism of mutual trust and establish a new system, in order to bridge the "last mile" of scientific research achievement transformation.
Jin Yi pointed out in his keynote speech that the role played by investors is actually to build a bridge in the process of transforming innovative achievements, and intellectual property is a very important foundation for this bridge. Intellectual property is not just a conventional patent, it is a complete management system. If the logic of investment is used to describe the ability of intellectual property, in fact, it can be fully reflected in the value of the entire chain of the four key links of fundraising, investment management, and withdrawal in investment. Taikang has combined its strong financial capabilities with professional intellectual property incubation and protection capabilities to jointly build an integrated investment capability of government, industry, academia, and research.
Wuhan has always attached great importance to the development of the biological industry. The biopharmaceutical industry in Wuhan is not only one of the first batch of biopharmaceutical industry clusters in China, but also a strategic pillar industry in the city, playing a pivotal role in accelerating the high-quality development of the big health industry. In the promotion of the biopharmaceutical industry, Bi Chao, the investment manager of the Industrial Department of the Wuhan National Biotech Industry Base Construction Service Center, and Liu Guanglei, the director of the investment promotion office of the Guanggu South Health Industry Park in Jiangxia District, Wuhan, respectively made on-site wonderful introductions to the Guanggu Biotech City and Guanggu South Health Industry Park, two important bases for building biopharmaceutical and health industry clusters in Wuhan.
The transformation of industry university research innovation cannot be achieved without high-quality scientific research results created by high-level scientists. At the project roadshow of this forum, six outstanding scientists from Wuhan University - Liu Tiangang, Chen Gang, Yu Lilei, Li Zhen, Chen Pu, and Liu Wei - shared their latest scientific research achievements on site, covering multiple cutting-edge fields such as biopharmaceuticals, diagnostic testing, clinical treatment, and medical materials, including many mature projects recognized by the investment market and mid-term projects seeking to expand investment, And the early projects that are still in the incubation stage of the laboratory have received high attention and recognition from the attending guests.
After the main agenda of the forum was concluded, a small closed door meeting was also held, inviting 6 guests from the roadshow to communicate and collide with more than 10 well-known investors, entrepreneurs, and legal experts. Liu Tingjun, President and Chief Operating Officer of Taikang Insurance Group, attended. Experts attending the roadshow answered questions and answered questions about the confusion and issues raised by the guests in the process of industry university research transformation, as well as conducted consultations and pulse analysis. The meeting was lively and everyone expressed that they had gained a lot. Liu Tingjun stated that Taikang will persist in organizing forums, building platforms, and exploring a new model and path for industry university research innovation and transformation in the field of big health. In the future, with the support and guidance of the Wuhan Municipal Bureau of Commerce and the Wuhan Investment Promotion Office, relying on the scientific research and clinical capabilities of Wuhan University Taikang Medical College (Basic Medical College) and Taikang Life Medicine Center, we will continue to promote the integration of medical education and research, transform the innovative achievements of high-end talents into real productivity, and lay the foundation for building a super platform that organically combines medical education, research, government industry and investment in the future, ultimately meeting people's needs for longevity, health, and wealth. (Information source: Taikang Health Investment official account)
